Clinical Evaluation of a Paediatric Sleep Diagnosis Technology

Sponsor
Acurable Ltd. (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04031950
Collaborator
Sheffield Children's NHS Foundation Trust (Other)
150
1
28.3
5.3

Study Details

Study Description

Brief Summary

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography.

Condition or Disease Intervention/Treatment Phase
  • Device: Novel wearable paediatric device

Detailed Description

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography.

Patients who are referred to the clinic will spend one night's sleep in the clinic. They will wear a polysomnography system (current goldstandard) and the novel device.

At the end of the trial, we will compare the diagnosis results from both systems.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Clinical Evaluation of a Paediatric Sleep Diagnosis Technology
Actual Study Start Date :
Feb 19, 2020
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
test group

Test group will wear PSG

Device: Novel wearable paediatric device
The patient will wear the novel wearable paediatric device at the same time as polysmnography

Novel wearable device

THis group will wear the novel device

Device: Novel wearable paediatric device
The patient will wear the novel wearable paediatric device at the same time as polysmnography

Outcome Measures

Primary Outcome Measures

  1. Specificity and sensitivity of novel device [6 months]

    specificity and sensitivity of the output of the novel wearable device against polysomnography

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children older than one year old

  • Children who have been referred to a sleep clinic due to suspicion of sleep apnoea.

Exclusion Criteria:
  • Patients whose parents/legal guardians/carers are not fluent in English, or who have special communication needs.

  • Known allergy to the adhesive dressing.

  • Patients with physical or mental impairments who would be too distressed with additional sensors on themselves.

  • Patients with not enough space on the neck area to fit the sensor.

  • Clinical problem in the area in which the device will be attached, eg skin condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sheffield Children Hospital Sheffield United Kingdom S10 2TH

Sponsors and Collaborators

  • Acurable Ltd.
  • Sheffield Children's NHS Foundation Trust

Investigators

  • Study Director: Ruth Kingshott, PhD, Sheffield Children's NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Acurable Ltd.
ClinicalTrials.gov Identifier:
NCT04031950
Other Study ID Numbers:
  • 269747
First Posted:
Jul 25, 2019
Last Update Posted:
Feb 16, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2022